The Resistance of Cervical Cancer to Chemotherapy and its Reversal provides a holistic understanding of cervical cancer development, immune-evading mechanisms of HPV, immunotherapies available, methods to study cervical cancer and the development of newer drugs. Content shows the involvement of signaling pathways during chemoresistance in cervical cancer, the involvement of genes in drug resistance, and introduces long noncoding RNAs as novel biomarkers. In 10 chapters, this book first provides an introduction and history of cervical cancer; next, it discusses the influence of viruses on cervical cancer and finally, it describes therapies to overcome chemotherapy resistance in cervical cancer. This is the perfect reference to provide the fundamental base of knowledge needed for oncologists, pharmacologists, translational investigators, immunotherapists, scientists, and clinicians interested in building a comprehensive understanding of the field.
Table of Contents
1. Wnt signalling and cervical cancer 2. Pharmacologial targets of cervical cancer 3. PD-1, HPV and cervical cancer 4. Radiotherapy and cervical cancer 5. HPV and cervical cancer 6. EGFR and cervical cancer 7. Protein engineering for cervical cancer 8. Anti-virals and cervical cancer 9. Advances in cytological screening for cervical cancer 10. microRNA and cervical cancer 11. Computer aided drug designing for cervical cancer 12. Nanoparticles for the treatment of cervical cancer
